Launched in 2019, the Syn-One Test is used by neurologists and other clinicians in all 50 states to aid in the diagnosis of synucleinopathies SCOTTSDALE, Ariz., /PRNewswire/ -- CND Life Sciences (CND) ...
Inclusion in the ENDO 1000 study in the UK for multiple sample types is presented as evidence of market validation for OraSure Technologies' collection kits, as described in the Q3 2025 earnings call, ...
Hepta, a biotechnology company using transformer-based AI to read the cell-free DNA (cfDNA) epigenome and detect ...